Skip to Content

RDY 612 (Pramipexole Dihydrochloride Extended-Release 0.75 mg)

Pill with imprint RDY 612 is White, Round and has been identified as Pramipexole Dihydrochloride Extended-Release 0.75 mg. It is supplied by Dr. Reddy's Laboratories Limited.

Pramipexole is used in the treatment of restless legs syndrome; parkinson's disease; periodic limb movement disorder; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RDY 612

Pramipexole dihydrochloride extended-release 0.75 mg RDY 612 Front
Pramipexole dihydrochloride extended-release 0.75 mg RDY 612 Back

Pramipexole Dihydrochloride Extended-Release

Imprint:
RDY 612
Strength:
0.75 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Dr. Reddy's Laboratories Limited
National Drug Code (NDC):
55111-0612

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide